Arbeitspapier
Predicting the on-study relapse rate for multiple sclerosis patients in clinical trials
- Sprache
-
Englisch
- Erschienen in
-
Series: Discussion Paper ; No. 430
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Held, U.
Heigenhauser, Ludwig
Chang, C.
Kappos, Ludwig
Polman, Chris
- Ereignis
-
Veröffentlichung
- (wer)
-
Ludwig-Maximilians-Universität München, Sonderforschungsbereich 386 - Statistische Analyse diskreter Strukturen
- (wo)
-
München
- (wann)
-
2005
- DOI
-
doi:10.5282/ubm/epub.1799
- Handle
- URN
-
urn:nbn:de:bvb:19-epub-1799-0
- Letzte Aktualisierung
-
10.03.2025, 11:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Held, U.
- Heigenhauser, Ludwig
- Chang, C.
- Kappos, Ludwig
- Polman, Chris
- Ludwig-Maximilians-Universität München, Sonderforschungsbereich 386 - Statistische Analyse diskreter Strukturen
Entstanden
- 2005
Ähnliche Objekte (12)
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Magnetic resonance techniques in clinical trials in multiple sclerosis
Predicting survival in cost-effectiveness analyses based on clinical trials
Knowledge Management Approaches for predicting Biomarker and assessing its Impact on Clinical Trials
Clinical trials in osteoporosis
Clinical trials in oncology
Incentives for clinical trials
Clinical trials in neurology
Fundamentals of clinical trials
Methodology of clinical drug trials
Responder identification in clinical trials
Statistics in clinical vaccine trials
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Magnetic resonance techniques in clinical trials in multiple sclerosis
Predicting survival in cost-effectiveness analyses based on clinical trials
Knowledge Management Approaches for predicting Biomarker and assessing its Impact on Clinical Trials
Clinical trials in osteoporosis
Clinical trials in oncology
Incentives for clinical trials
Clinical trials in neurology
Fundamentals of clinical trials
Methodology of clinical drug trials
Responder identification in clinical trials
Statistics in clinical vaccine trials
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Magnetic resonance techniques in clinical trials in multiple sclerosis
Predicting survival in cost-effectiveness analyses based on clinical trials
Knowledge Management Approaches for predicting Biomarker and assessing its Impact on Clinical Trials
Clinical trials in osteoporosis
Clinical trials in oncology
Incentives for clinical trials
Clinical trials in neurology
Fundamentals of clinical trials
Methodology of clinical drug trials
Responder identification in clinical trials